Biotech BIOPHARM WINS EXCELLENCE IN GENERIC MEDICINE DEVELOPMENT IN ALGERIA AT THE GLOBAL BRAND AWARDS 2024 April 2, 2025
Biotech Landmark Bio Acquired by Artis BioSolutions to Expand Manufacturing and Commercialization of Advanced Therapies April 2, 2025
Biotech Edgewise Therapeutics Announces Positive Top-Line Results from Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) April 2, 2025
Biotech IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events April 1, 2025
Biotech Plant Biotechnology Market worth $76.79 billion by 2030- Exclusive Report by MarketsandMarkets™ April 1, 2025
Biotech IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma March 31, 2025
Biotech Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology March 30, 2025
Biotech Virion Therapeutics Reports Positive Clinical Data with VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure, at APASL 2025 Global Liver Meeting March 29, 2025